| Literature DB >> 29296142 |
Guillaume Ngoie Mwamba1, Norbert Yoloyolo1, Yolande Masembe2, Muriel Nzazi Nsambu2, Cathy Nzuzi1, Patrice Tshekoya1, Barthelemy Dah2, Guylain Kaya1.
Abstract
INTRODUCTION: Vaccination coverage of the first dose of diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenza type b (pentavalent) vaccine for the City-Province of Kinshasain the years 2012 - 2014 wasbelow the national objective of 92%, with coverage less than 80% reported in 12 of the 35 health zones (HZ). The purpose of this study was to discern potential contributing factors to low vaccination coverage in Kinshasa.Entities:
Keywords: Routine Immunization; reaching every district; routine vaccination; urban
Mesh:
Substances:
Year: 2017 PMID: 29296142 PMCID: PMC5745950 DOI: 10.11604/pamj.supp.2017.27.3.11930
Source DB: PubMed Journal: Pan Afr Med J
Target population and coverage of first dose of pentavalent vaccine (Penta1) in 12 high risk Health Zones in Kinshasa, DRC, data Jan-July 2014
| Health zone | Target population EPI, 0-11 months | Coverage Penta1 | Children 0-11 months not vaccinated, Penta1 |
|---|---|---|---|
| Bandalungwa | 6,661 | 73% | 899 |
| Barumbu | 5,567 | 46% | 1,503 |
| Binza-Ozone | 13,718 | 55% | 3,087 |
| Bumbu | 15,190 | 62% | 2,886 |
| Kalamu I | 5,347 | 78% | 588 |
| Kingasani | 8,123 | 62% | 1,543 |
| Kintambo | 3,837 | 59% | 787 |
| Lemba | 11,805 | 64% | 2,125 |
| Lingwala | 3,154 | 51% | 773 |
| Makala | 11,274 | 60% | 2,255 |
| Masina I | 12,247 | 61% | 2,388 |
| Ngaba | 6,670 | 67% | 1,101 |
| Total | 103,593 | 61% | 19,935 |
Source : DRCMinistry of Health EPI database:January to June 2014
Demographic characteristics among households interviewed in 12 high risk HZ in Kinshasa, DRC (n=1224)
| N | % | |
|---|---|---|
|
| ||
| Masculine | 655 | 54 |
| Feminine | 568 | 46 |
|
| ||
| Home-basedcard | 860 | 74 |
| Facility based register (no card) | 104 | 9 |
| Caregiverrecallonly | 206 | 18 |
|
| ||
| First | 387 | 32 |
| 2-4 | 665 | 54 |
| 5-9 | 171 | 14 |
|
| ||
| 3m-11m | 315 | 27 |
| 12-23m | 248 | 21 |
| 24-59m | 342 | 29 |
| 5+yrs | 276 | 23 |
|
| ||
| <20yrs | 101 | 9 |
| 20 – 24 yrs | 291 | 25 |
| 25 – 29 yrs | 334 | 28 |
| 30 – 34 yrs | 243 | 21 |
| 35 – 39 yrs | 163 | 14 |
| 40+ yrs | 47 | 4 |
|
| ||
| Married/cohabitation | 970 | 79 |
| Not married | 252 | 21 |
|
| ||
| None | 60 | 5 |
| Primary | 885 | 73 |
| Secondary | 254 | 21 |
| Post-secondary | 6 | 1 |
|
| ||
| Catholic | 151 | 12 |
| Other Christian | 989 | 81 |
| Muslim | 15 | 1 |
| Other | 71 | 6 |
|
| ||
| Works outside the home/student | 418 | 34 |
| None/housewife | 803 | 66 |
|
| ||
| Yes | 1146 | 94 |
| No | 74 | 6 |
|
| ||
| 2-4 | 342 | 28 |
| 5-9 | 684 | 56 |
| 10+ | 194 | 16 |
Numbers excludemissing data
Vaccination coverage among children 6-11 months old living in 12 high risk Health Zones in Kinshasa, DRC, by antigen+ (N=1224)
|
|
| |||
|---|---|---|---|---|
|
|
|
| ||
| BCG | Birth | 1196 | 98 | 96, 98 |
| OPV0 | Birth | 1147 | 94 | 91, 95 |
| OPV1 | 6 weeks | 1144 | 93 | 91, 95 |
| OPV2 | 10 weeks | 1079 | 88 | 85, 90 |
| OPV3 | 14 weeks | 962 | 77 | 74, 80 |
| Penta1 | 6 weeks | 1168 | 96 | 94, 97 |
| Penta2 | 10 weeks | 1142 | 93 | 91, 95 |
| Penta3 | 14 weeks | 1035 | 84 | 81, 87 |
| PCV1 | 6 weeks | 1164 | 95 | 93, 97 |
| PCV2 | 10 weeks | 1131 | 93 | 91, 94 |
| PCV3 | 14 weeks | 1028 | 84 | 81, 86 |
| MCV | 9 months | 327 | 85 | 80, 88 |
| Yellow Fever | 9 months | 325 | 84 | 80, 88 |
| Up-to-date for age | 889 | 71 | 68, 75 | |
BCG=Bacille Calmette Guerin; OPV= Oral Polio Vaccine ; Penta= Pentavalent (diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenza type b); PCV=Pneumococcal Conjugate Vaccine ; MCV=Measles Containing Vaccine
combined data from immunization card, verbal history, and immunization registry
children 10-11 mo
The estimated intra-class correlation (ICC) for Penta3 among 6-11 month olds (average cluster size = 6.8) was 0.12, and among 12-23 month olds was 0.03 (average cluster size = 4.0)
Vaccination coverage among children living in 12 high risk Health Zones in Kinshasa, DRC, by zone+
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| Bandalungwa | 96 | 91, 100 | 83 | 69, 97 |
| Barumbu | 93 | 89, 98 | 79 | 63, 94 |
| Binza-Ozone | 96 | 91, 100 | 79 | 64, 93 |
| Bumbu | 97 | 94, 100 | 82 | 72, 92 |
| Kalamu I | 93 | 87, 99 | 85 | 74, 97 |
| Kingasani | 94 | 89, 100 | 86 | 68, 100 |
| Kintambo | 94 | 89, 99 | 76 | 55, 96 |
| Lemba | 98 | 94, 100 | 86 | 69, 100 |
| Lingwala | 98 | 95, 100 | 97 | 89, 100 |
| Makala | 90 | 80, 100 | 88 | 77, 99 |
| Masina I | 99 | 97, 100 | 93 | 84, 100 |
| Ngaba | 96 | 92, 100 | 89 | 76, 100 |
combined data from immunization card, verbal history, and immunization registry
children 10-11 mo
Characteristics of children residing in 12 high risk Health Zones in Kinshasa, DRC, by vaccination status (N=1224)
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| 0.27 | ||||||
| Masculine | 469 | 70 | 65, 74 | 186 | 30 | 26, 34 | |
| Feminine | 420 | 73 | 68, 78 | 148 | 27 | 22, 32 | |
|
|
| ||||||
| Yes | 843 | 76 | 72, 79 | 249 | 24 | 21, 28 | |
| No | 46 | 37 | 27, 48 | 86 | 63 | 52, 73 | |
|
|
| ||||||
| 0-15 minutes | 417 | 77 | 71, 81 | 113 | 23 | 19, 29 | |
| 16–30 minutes | 240 | 75 | 69, 80 | 79 | 25 | 20, 30 | |
| >30 minutes | 117 | 66 | 58, 72 | 60 | 34 | 28, 42 | |
|
| 0.75 | ||||||
| Free | 80 | 69 | 58, 78 | 31 | 31 | 21, 42 | |
| 1-500FC | 294 | 74 | 69, 79 | 98 | 26 | 21, 31 | |
| 501-2000FC | 360 | 75 | 70, 79 | 116 | 25 | 21, 30 | |
| >2000FC | 126 | 73 | 64, 81 | 42 | 27 | 20, 36 | |
|
| 0.04 | ||||||
| 3m-11m | 210 | 65 | 58, 71 | 105 | 35 | 29, 42 | |
| 12-23m | 181 | 71 | 65, 77 | 67 | 29 | 23, 35 | |
| 24-59m | 259 | 75 | 70, 80 | 83 | 25 | 20, 30 | |
| 5+years | 206 | 74 | 67, 80 | 70 | 26 | 20, 33 | |
Numbers exclude missing data
Up to date – child received all antigens recommended for age at the time of the survey
Figure 1Factor cited by respondent as most important in choice of health facility for most recent vaccination, 12 high risk Health Zones in Kinshasa, DRC